| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |